Cargando…
Current status of NADPH oxidase research in cardiovascular pharmacology
The implications of reactive oxygen species in cardiovascular disease have been known for some decades. Rationally, therapeutic antioxidant strategies combating oxidative stress have been developed, but the results of clinical trials have not been as good as expected. Therefore, to move forward in t...
Autores principales: | Rodiño-Janeiro, Bruno K, Paradela-Dobarro, Beatriz, Castiñeiras-Landeira, María Isabel, Raposeiras-Roubín, Sergio, González-Juanatey, José R, Álvarez, Ezequiel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3750863/ https://www.ncbi.nlm.nih.gov/pubmed/23983473 http://dx.doi.org/10.2147/VHRM.S33053 |
Ejemplares similares
-
Fluorescent Advanced Glycation End Products and Their Soluble Receptor: The Birth of New Plasmatic Biomarkers for Risk Stratification of Acute Coronary Syndrome
por: Raposeiras-Roubín, Sergio, et al.
Publicado: (2013) -
Predictive value of advanced glycation end products for the development of post-infarction heart failure: a preliminary report
por: Raposeiras-Roubín, Sergio, et al.
Publicado: (2012) -
NADPH oxidases: Current aspects and tools
por: Schröder, Katrin
Publicado: (2020) -
(Poly)phenols and the regulation of NADPH oxidases
por: Fraga, Cesar G., et al.
Publicado: (2023) -
Comparative pharmacology of chemically distinct NADPH oxidase inhibitors
por: Wind, S, et al.
Publicado: (2010)